516 . Cite . What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B? Petrini P. Petrini P. . Cite . Özcan A, et al. Nature. 2021 Sep 6. doi: 10.1038/s41586-021-03886-5. Online ahead of print. Nature. 2021. PMID: 34489594 Page Menu News Page Menu News Gluten intolerance a significant risk factor Infectious disease of the uterus Absence of an individual specific disease Page Menu News